Preview

Nephrology (Saint-Petersburg)

Advanced search

Physical performance of patients with chronic kidney disease stage 5D and coronary heart disease

https://doi.org/10.36485/1561-6274-2023-27-1-78-85

Abstract

   BACKGROUND. Assessment of physical performance in patients is usually based on the results of the 6-minute walk test, which is primarily associated with heart or respiratory failure.

   THE AIM: to analyze the results of the 6-minute walk test with clinical and laboratory parameters of patients with CKD 5D, including criteria for protein-energy malnutrition.

   PATIENTS AND METHODS. 67 people with CKD 5D were examined, including 42 men and 25 women, mean age 49.0 ± 14.9 and 57.2 ± 15.5 years, respectively, p = 0.036. The duration of RRT in men was 96.1 ± 80.3 months, in women 100.7 ± 66.1 months, p = 0.810. The diagnosis of coronary heart disease was established in 22 people, 7 of them had AMI. The muscle strength of the skeletal muscles was assessed using a hand dynamometer, the performance of the skeletal muscles – during a test with a 6-minute walk. All patients filled out food diaries, where they indicated the qualitative and quantitative composition of the food which they consumed for 3 days.

   RESULTS. Walking load was most easily tolerated by patients without clinical manifestations of CAD. Between patients with and without AMI in history, the number of points on the Borg scale was comparable and reached the maximum values. The highest concentration of C-reactive protein and the lowest concentration of serum albumin were observed in patients who had had AMI. Relationships were found between serum albumin with C-reactive protein and the results of the 6-minute walk test, as well as between the mass index of the left ventricular myocardium with the results of the 6-minute walk test.

   CONCLUSION. Left ventricular hypertrophy masks the clinical signs of reduced physical performance, but increases the risk of cardiovascular complications. The results of the 6-minute walk test in patients with CAD should be evaluated in more detail. A number of studies are needed to clarify how dietary recommendations should be modified depending on the level of systemic inflammation in CKD.

About the Authors

N. Yu. Korosteleva
Pavlov Saint-Petersburg State University named after Academician I. P. Pavlova
Russian Federation

Natalya Yu. Korosteleva, MD, Ph.D, Senior Researcher

Research Institute of Nephrology

197022

st. Leo Tolstoy, 6–8

St. Petersburg

Phone: +7 (911) 918-45-49



A. Sh. Rumyantsev
Saint-Petersburg State University; Pavlov Saint-Petersburg State University named after Academician I. P. Pavlova
Russian Federation

Aleksandr Sh. Rumyantsev, Prof., MD, PhD, DMedSci

Department of Faculty Therapy

199106

21st line V. O., 8a

Department of Propaedeutics of Internal Diseases

197022

st. Leo Tolstoy, 6–8

St. Petersburg

Tel.: +7 (812) 326-03-26

+7 (911) 267-74-13



M. Kh. Khasun
Pavlov Saint-Petersburg State University named after Academician I. P. Pavlova
Russian Federation

Mohamad Kh. Khasun, MD, Ph.D

Department of Propaedeutics of Internal Diseases

197022

st. L. Tolstoy, d. 17, building. 54

St. Petersburg

Phone: (812) 346-39-26



B. G. Lukichev
Pavlov Saint-Petersburg State University named after Academician I. P. Pavlova
Russian Federation

Boris G. Lukichev, Prof., MD, PhD, DMedSci

Department of Propaedeutics of Internal Diseases

197022

st. L. Tolstoy, d. 17

St. Petersburg

Phone: (812) 234-01-65



E. B. Lebedeva
Pavlov Saint-Petersburg State University named after Academician I. P. Pavlova
Russian Federation

Elvira B. Lebedeva, senior laboratory assistant

Research Institute of Nephrology

197022

st. Leo Tolstoy, d. 6-8

St. Petersburg

Phone: 8 951 643 35 54



E. V. Grigoryan
Pavlov Saint-Petersburg State University named after Academician I. P. Pavlova
Russian Federation

Ekaterina V. Grigoryan

Research Institute of Nephrology

197022

st. Leo Tolstoy, d. 6-8

St. Petersburg

Phone: 8 921 326 48 55



N. N. Kulaeva
Clinical Pharmacology and Neurology, I. I. Mechnikov Northwestern State Medical University
Russian Federation

Natalya N. Kulaeva, Associate Professor, Candidate of Medical Sciences

Department of Internal Diseases

195067

Piskarevsky pr., 47

St. Petersburg

Phone: +79213469764



References

1. Kirkman D. L., Bohmke N., Carbone S. et al. Exercise intolerance in kidney diseases: physiological contributors and therapeutic strategies. Am J Physiol Renal Physiol 2021 Feb 1; 320 (2): F161–F173. doi: 10.1152/ajprenal.00437.2020

2. Bakker E. A., Zoccali C., Dekker F. W., Eijsvogels T. M. H., Jager K. J. Assessing physical activity and function in patients with chronic kidney disease: a narrative review. Clin Kidney J 2020 Sep 8; 14 (3): 768–779. URL: https://pubmed.ncbi.nlm.nih.gov/33777360/

3. Fouque D., Kalantar-Zadeh K., Kopple J. et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 2008 Feb; 73 (4): 391–388. doi: 10.1038/sj.ki.5002585

4. Cruz-Jentoft A. J., Bahat G., Bauer J., Boirie Y. et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 2019 Jan 1; 48 (1): 16–31. doi: 10.1093/ageing/afy169

5. Bučar Pajek M., Čuk I., Leskošek B., Mlinšek G., Buturović Ponikvar J., Pajek J. Six-Minute Walk Test in Renal Failure Patients: Representative Results, Performance Analysis and Perceived Dyspnea Predictors. PLoS One 2016 Mar 16; 11 (3): e0150414. doi: 10.1371/journal.pone.0150414

6. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002 Jul 1; 166 (1): 111–117. doi: 10.1164/ajrccm.166.1.at1102

7. Borg G. Borg’s perceived exertion and pain scales. Champaign: Human Kinetcs, 1998; 104

8. Ikizler T. A., Burrowes J. D., Byham-Gray L. D. et al. KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update. Am J Kidney Dis 2020 Sep; 76 (3 Suppl 1): S1–S107. doi: 10.1053/j.ajkd.2020.05.006

9. McCullough P. A., Chan C. T., Weinhandl E. D. et al. Intensive Hemodialysis, Left Ventricular Hypertrophy, and Cardiovascular Disease. Am J Kidney Dis 2016 Nov; 68 (5S1): S5–S14. doi: 10.1053/j.ajkd.2016.05.025

10. Makar M. S., Pun P. H. Sudden Cardiac Death Among Hemodialysis Patients. Am J Kidney Dis 2017 May; 69 (5): 684–695.


Review

For citations:


Korosteleva N.Yu., Rumyantsev A.Sh., Khasun M.Kh., Lukichev B.G., Lebedeva E.B., Grigoryan E.V., Kulaeva N.N. Physical performance of patients with chronic kidney disease stage 5D and coronary heart disease. Nephrology (Saint-Petersburg). 2023;27(1):78-85. (In Russ.) https://doi.org/10.36485/1561-6274-2023-27-1-78-85

Views: 490


ISSN 1561-6274 (Print)
ISSN 2541-9439 (Online)